Worsening of motor performance in patients with Parkinson's disease following transdermal nicotine administration
Identifieur interne : 004C04 ( Main/Exploration ); précédent : 004C03; suivant : 004C05Worsening of motor performance in patients with Parkinson's disease following transdermal nicotine administration
Auteurs : Georg Ebersbach [Autriche] ; Michael Stöck [Autriche] ; Jörg Müller [Autriche] ; Gregor Wenning [Autriche] ; Jörg Wissel [Autriche] ; Werner Poewe [Autriche]Source :
- Movement Disorders [ 0885-3185 ] ; 1999-11.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
- Administration, Cutaneous, Adult, Aged, Antiparkinson Agents (administration & dosage), Antiparkinson Agents (adverse effects), Corpus Striatum (drug effects), Corpus Striatum (physiology), Cross-Over Studies, Dopamine (physiology), Double-Blind Method, Drug Therapy, Combination, Female, Human, Humans, Male, Middle Aged, Motor Skills (drug effects), Motor Skills (physiology), Motor performance, Motor system disorder, Neural Inhibition (drug effects), Neural Inhibition (physiology), Nicotine, Nicotine (administration & dosage), Nicotine (adverse effects), Parkinson Disease (drug therapy), Parkinson Disease (physiopathology), Parkinson disease, Parkinson's disease, Patch, Route of administration, Substantia Nigra (drug effects), Substantia Nigra (physiopathology), Toxicity.
- MESH :
- chemical , administration & dosage : Antiparkinson Agents, Nicotine.
- chemical , adverse effects : Antiparkinson Agents, Nicotine.
- drug effects : Corpus Striatum, Motor Skills, Neural Inhibition, Substantia Nigra.
- drug therapy : Parkinson Disease.
- physiology : Corpus Striatum, Dopamine, Motor Skills, Neural Inhibition.
- physiopathology : Parkinson Disease, Substantia Nigra.
- Administration, Cutaneous, Adult, Aged, Cross-Over Studies, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Male, Middle Aged.
Abstract
Nicotine has been reported to have positive effects on motor performance in patients with Parkinson's disease. In this study, motor performance was evaluated in 16 patients with idiopathic Parkinson's disease during a practical off‐period using the motor part of the Unified Parkinson's Disease Rating Scale after 12 hours' exposure to a transdermal patch containing 35 mg nicotine or placebo. The study was performed using a double‐blind crossover design. In contrast to previous reports, nicotine exposure was followed by a worsening of symptoms compared with placebo. A negative response to subthreshold dopaminergic stimulation, resulting from an inhibitory effect of low striatal dopamine concentrations acting on a subset of dopamine receptors, might possibly account for this finding.
Url:
DOI: 10.1002/1531-8257(199911)14:6<1011::AID-MDS1016>3.0.CO;2-F
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 003618
- to stream Istex, to step Curation: 003618
- to stream Istex, to step Checkpoint: 003370
- to stream Main, to step Merge: 007902
- to stream PascalFrancis, to step Corpus: 002D02
- to stream PascalFrancis, to step Curation: 000019
- to stream PascalFrancis, to step Checkpoint: 002C86
- to stream Main, to step Merge: 007B35
- to stream PubMed, to step Corpus: 004087
- to stream PubMed, to step Curation: 004087
- to stream PubMed, to step Checkpoint: 004069
- to stream Ncbi, to step Merge: 000164
- to stream Ncbi, to step Curation: 000164
- to stream Ncbi, to step Checkpoint: 000164
- to stream Main, to step Merge: 007676
- to stream Main, to step Curation: 004C04
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Worsening of motor performance in patients with Parkinson's disease following transdermal nicotine administration</title>
<author><name sortKey="Ebersbach, Georg" sort="Ebersbach, Georg" uniqKey="Ebersbach G" first="Georg" last="Ebersbach">Georg Ebersbach</name>
</author>
<author><name sortKey="Stock, Michael" sort="Stock, Michael" uniqKey="Stock M" first="Michael" last="Stöck">Michael Stöck</name>
</author>
<author><name sortKey="Muller, Jorg" sort="Muller, Jorg" uniqKey="Muller J" first="Jörg" last="Müller">Jörg Müller</name>
</author>
<author><name sortKey="Wenning, Gregor" sort="Wenning, Gregor" uniqKey="Wenning G" first="Gregor" last="Wenning">Gregor Wenning</name>
</author>
<author><name sortKey="Wissel, Jorg" sort="Wissel, Jorg" uniqKey="Wissel J" first="Jörg" last="Wissel">Jörg Wissel</name>
</author>
<author><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name>
<affiliation><country>Autriche</country>
<placeName><settlement type="city">Innsbruck</settlement>
<region nuts="2" type="region">Tyrol (Land)</region>
</placeName>
<orgName type="university">Université de médecine d'Innsbruck</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:38FB2ADD91058F41ABAF5A1581A5916EFC2D82A7</idno>
<date when="1999" year="1999">1999</date>
<idno type="doi">10.1002/1531-8257(199911)14:6<1011::AID-MDS1016>3.0.CO;2-F</idno>
<idno type="url">https://api.istex.fr/document/38FB2ADD91058F41ABAF5A1581A5916EFC2D82A7/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003618</idno>
<idno type="wicri:Area/Istex/Curation">003618</idno>
<idno type="wicri:Area/Istex/Checkpoint">003370</idno>
<idno type="wicri:doubleKey">0885-3185:1999:Ebersbach G:worsening:of:motor</idno>
<idno type="wicri:Area/Main/Merge">007902</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:00-0008054</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002D02</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000019</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002C86</idno>
<idno type="wicri:doubleKey">0885-3185:1999:Ebersbach G:worsening:of:motor</idno>
<idno type="wicri:Area/Main/Merge">007B35</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:10584678</idno>
<idno type="wicri:Area/PubMed/Corpus">004087</idno>
<idno type="wicri:Area/PubMed/Curation">004087</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004069</idno>
<idno type="wicri:Area/Ncbi/Merge">000164</idno>
<idno type="wicri:Area/Ncbi/Curation">000164</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000164</idno>
<idno type="wicri:doubleKey">0885-3185:1999:Ebersbach G:worsening:of:motor</idno>
<idno type="wicri:Area/Main/Merge">007676</idno>
<idno type="wicri:Area/Main/Curation">004C04</idno>
<idno type="wicri:Area/Main/Exploration">004C04</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Worsening of motor performance in patients with Parkinson's disease following transdermal nicotine administration</title>
<author><name sortKey="Ebersbach, Georg" sort="Ebersbach, Georg" uniqKey="Ebersbach G" first="Georg" last="Ebersbach">Georg Ebersbach</name>
<affiliation wicri:level="1"><country xml:lang="fr">Autriche</country>
<wicri:regionArea>Department of Neurology, University Clinic Innsbruck, Innsbruck</wicri:regionArea>
<wicri:noRegion>Innsbruck</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Stock, Michael" sort="Stock, Michael" uniqKey="Stock M" first="Michael" last="Stöck">Michael Stöck</name>
<affiliation wicri:level="1"><country xml:lang="fr">Autriche</country>
<wicri:regionArea>Department of Neurology, University Clinic Innsbruck, Innsbruck</wicri:regionArea>
<wicri:noRegion>Innsbruck</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Muller, Jorg" sort="Muller, Jorg" uniqKey="Muller J" first="Jörg" last="Müller">Jörg Müller</name>
<affiliation wicri:level="1"><country xml:lang="fr">Autriche</country>
<wicri:regionArea>Department of Neurology, University Clinic Innsbruck, Innsbruck</wicri:regionArea>
<wicri:noRegion>Innsbruck</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wenning, Gregor" sort="Wenning, Gregor" uniqKey="Wenning G" first="Gregor" last="Wenning">Gregor Wenning</name>
<affiliation wicri:level="1"><country xml:lang="fr">Autriche</country>
<wicri:regionArea>Department of Neurology, University Clinic Innsbruck, Innsbruck</wicri:regionArea>
<wicri:noRegion>Innsbruck</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wissel, Jorg" sort="Wissel, Jorg" uniqKey="Wissel J" first="Jörg" last="Wissel">Jörg Wissel</name>
<affiliation wicri:level="1"><country xml:lang="fr">Autriche</country>
<wicri:regionArea>Department of Neurology, University Clinic Innsbruck, Innsbruck</wicri:regionArea>
<wicri:noRegion>Innsbruck</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name>
<affiliation wicri:level="1"><country xml:lang="fr">Autriche</country>
<wicri:regionArea>Department of Neurology, University Clinic Innsbruck, Innsbruck</wicri:regionArea>
<wicri:noRegion>Innsbruck</wicri:noRegion>
<placeName><settlement type="city">Innsbruck</settlement>
<region nuts="2" type="region">Tyrol (Land)</region>
</placeName>
<orgName type="university">Université de médecine d'Innsbruck</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>John Wiley & Sons, Inc.</publisher>
<pubPlace>New York</pubPlace>
<date type="published" when="1999-11">1999-11</date>
<biblScope unit="vol">14</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="1011">1011</biblScope>
<biblScope unit="page" to="1013">1013</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">38FB2ADD91058F41ABAF5A1581A5916EFC2D82A7</idno>
<idno type="DOI">10.1002/1531-8257(199911)14:6<1011::AID-MDS1016>3.0.CO;2-F</idno>
<idno type="ArticleID">MDS1016</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Cutaneous</term>
<term>Adult</term>
<term>Aged</term>
<term>Antiparkinson Agents (administration & dosage)</term>
<term>Antiparkinson Agents (adverse effects)</term>
<term>Corpus Striatum (drug effects)</term>
<term>Corpus Striatum (physiology)</term>
<term>Cross-Over Studies</term>
<term>Dopamine (physiology)</term>
<term>Double-Blind Method</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Human</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Motor Skills (drug effects)</term>
<term>Motor Skills (physiology)</term>
<term>Motor performance</term>
<term>Motor system disorder</term>
<term>Neural Inhibition (drug effects)</term>
<term>Neural Inhibition (physiology)</term>
<term>Nicotine</term>
<term>Nicotine (administration & dosage)</term>
<term>Nicotine (adverse effects)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (physiopathology)</term>
<term>Parkinson disease</term>
<term>Parkinson's disease</term>
<term>Patch</term>
<term>Route of administration</term>
<term>Substantia Nigra (drug effects)</term>
<term>Substantia Nigra (physiopathology)</term>
<term>Toxicity</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Nicotine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Nicotine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Corpus Striatum</term>
<term>Motor Skills</term>
<term>Neural Inhibition</term>
<term>Substantia Nigra</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Corpus Striatum</term>
<term>Dopamine</term>
<term>Motor Skills</term>
<term>Neural Inhibition</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Parkinson Disease</term>
<term>Substantia Nigra</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Administration, Cutaneous</term>
<term>Adult</term>
<term>Aged</term>
<term>Cross-Over Studies</term>
<term>Double-Blind Method</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Homme</term>
<term>Nicotine</term>
<term>Parkinson maladie</term>
<term>Patch</term>
<term>Toxicité</term>
<term>Trouble moteur</term>
<term>Voie administration</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Nicotine has been reported to have positive effects on motor performance in patients with Parkinson's disease. In this study, motor performance was evaluated in 16 patients with idiopathic Parkinson's disease during a practical off‐period using the motor part of the Unified Parkinson's Disease Rating Scale after 12 hours' exposure to a transdermal patch containing 35 mg nicotine or placebo. The study was performed using a double‐blind crossover design. In contrast to previous reports, nicotine exposure was followed by a worsening of symptoms compared with placebo. A negative response to subthreshold dopaminergic stimulation, resulting from an inhibitory effect of low striatal dopamine concentrations acting on a subset of dopamine receptors, might possibly account for this finding.</div>
</front>
</TEI>
<affiliations><list><country><li>Autriche</li>
</country>
<region><li>Tyrol (Land)</li>
</region>
<settlement><li>Innsbruck</li>
</settlement>
<orgName><li>Université de médecine d'Innsbruck</li>
</orgName>
</list>
<tree><country name="Autriche"><noRegion><name sortKey="Ebersbach, Georg" sort="Ebersbach, Georg" uniqKey="Ebersbach G" first="Georg" last="Ebersbach">Georg Ebersbach</name>
</noRegion>
<name sortKey="Muller, Jorg" sort="Muller, Jorg" uniqKey="Muller J" first="Jörg" last="Müller">Jörg Müller</name>
<name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name>
<name sortKey="Stock, Michael" sort="Stock, Michael" uniqKey="Stock M" first="Michael" last="Stöck">Michael Stöck</name>
<name sortKey="Wenning, Gregor" sort="Wenning, Gregor" uniqKey="Wenning G" first="Gregor" last="Wenning">Gregor Wenning</name>
<name sortKey="Wissel, Jorg" sort="Wissel, Jorg" uniqKey="Wissel J" first="Jörg" last="Wissel">Jörg Wissel</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004C04 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004C04 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:38FB2ADD91058F41ABAF5A1581A5916EFC2D82A7 |texte= Worsening of motor performance in patients with Parkinson's disease following transdermal nicotine administration }}
This area was generated with Dilib version V0.6.23. |